Psychiatric pathology and water intake: not always psychogenic polydipsia
DOI:
https://doi.org/10.32818/reccmi.a3n3a14Keywords:
nephrogenic diabetes insipidus, lithium carbonate , bipolar disorder , polydipsia, acetazolamideAbstract
A 55-year-old woman, with a history of mixed bipolar disorder, is labeled as having psychogenic polydipsia due to a large daily intake of water and other fluids during the past few months. She is admitted to the Emergency Room because of severe hypernatraemia and acute kidney injury, forcing us to reconsider this diagnosis.
Downloads
Metrics
References
Gordon CE, Vantzelfde S, Francis JM. Acetazolamide in lithium-induced nephrogenic diabetes insipidus. N Engl J Med. 2016 Nov 17; 375(20): 2008-2009. doi: https://doi.org/10.1056/NEJMc1609483.
de Groot T, Doornebal J, Christensen BM, Cockx S, Sinke AP, Baumgarten R, et al. Lithium-induced NDI: acetazolamide reduces polyuria but does notimprove urine concentrating ability. Am J Physiol Renal Physiol. 2017 Sep 1; 313(3): F669-F676. doi: https://doi.org/10.1152/ajprenal.00147.2017.
Macau RA, da Silva TN, Silva JR, Ferreira AG, Bravo P. Use of acetazolamide in lithium-induced nephrogenic diabetes insipidus: a case report. Endocrinol Diabetes Metab Case Rep. 2018 Feb 20; 2018. doi: https://doi.org/10.1530/EDM-17-0154.
McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta-analysis. Lancet. 2012; 379(9817): 721. doi: https://doi.org/10.1016/S0140-6736(11)61516-X.
Bockenhauer D, Bichet DG. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus. Nat Rev Nephrol. 2015 Oct; 11(10): 576-588. doi: https://doi.org/10.1038/nrneph.2015.89.
Fenske W, Refardt J, Chifu I, Schnyder I, Winzeler B, Drummond J, et al. A Copeptin-based approach in the diagnosis of diabetes insipidus. N Engl J Med. 2018; 379(5): 428. doi: https://doi.org/10.1056/NEJMoa1803760.
Bedford JJ, Weggery S, Ellis G, McDonald FJ, Joyce PR, Leader JP, et al. Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride. Clin J Am Soc Nephrol. 2008; 3(5): 1324. doi: https://doi.org/10.2215/CJN.01640408.
Libber S, Harrison H, Spector D. Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors. J Pediatr. 1986; 108(2): 305.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Guillermo Ropero-Luis, Ana Muñoz-Sánchez, Almudena López-Sampalo, Juan-José Mancebo-Sevilla, Ricardo Gómez-Huelgas
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
